Ultragenyx Pharmaceutical Inc (RARE) USD0.001
1.35%- This stock can be held in a
Stocks and Shares ISASell:$43.63
Buy:$43.71
Change:
$0.12
(0.27%)
$0.12
(0.27%)Market closed | Prices delayed by at least 15 minutes
Sell:$43.63
Buy:$43.71
Change:$0.12
(0.27%)
$0.12
(0.27%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 10 December 2024 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 8,273 | $50.00 | $413,650.00 | 2,195,712 |
| 10 October 2024 | Howard HornCFO | Sell Tax related | 7,465 | $52.76 | $393,853.40 | 92,301 |
| 3 September 2024 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 20,000 | $55.85 | $1,117,000.00 | 2,223,985 |
| 3 September 2024 | Theodore Alan (Ted) HuizengaChief Accounting Officer | Sell Tax related | 91 | $56.19 | $5,113.29 | 41,551 |
| 6 August 2024 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 20,000 | $50.17 | $1,003,400.00 | 2,243,985 |
| 2 July 2024 | Corazon Dating (Corsee) SandersIndependent Director | Sell Option/Award related | 584 | $40.98 | $23,932.32 | 12,009 |
| 12 June 2024 | Karah Herdman ParschauerChief Legal/Compliance Officer | Sell Regular sell transaction (market) | 9,806 | $45.00 | $441,270.00 | 57,981 |
| 10 June 2024 | Corazon Dating (Corsee) SandersIndependent Director | Sell Option/Award related | 1,737 | $41.10 | $71,390.70 | 7,248 |
| 2 May 2024 | Eric CrombezOther Level A | Sell Tax related | 354 | $43.66 | $15,455.64 | 48,431 |
| 18 April 2024 | Eric CrombezOther Level A | Sell Tax related | 142 | $44.10 | $6,262.20 | 48,785 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 29 December 2023 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 30,000 | $47.87 | $1,436,100.00 | 569,770 |
| 7 February 2024 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 30,000 | $45.00 | $1,350,000.00 | 539,770 |
| 3 September 2024 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 20,000 | $55.85 | $1,117,000.00 | 2,223,985 |
| 6 August 2024 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 20,000 | $50.17 | $1,003,400.00 | 2,243,985 |
| 1 March 2024 | Emil D KakkisChairman/CEO | Sell Tax related | 17,417 | $53.69 | $935,118.73 | 560,781 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.